Jefferies Group’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.61M | Buy |
+9,400
| New | +$2.65M | 0.02% | 517 |
|
|
2022
Q2 | – | Sell |
-1,522
| Closed | -$365K | – | 1582 |
|
|
2022
Q1 | $365K | Sell |
1,522
-3,178
| -68% | -$744K | ﹤0.01% | 1135 |
|
|
2021
Q4 | $1.08M | Sell |
4,700
-10,878
| -70% | -$2.31M | 0.01% | 979 |
|
|
2021
Q3 | $3.12M | Buy |
+15,578
| New | +$3.39M | 0.02% | 587 |
|
|
2021
Q2 | – | Sell |
-14,692
| Closed | -$3.55M | – | 1709 |
|
|
2021
Q1 | $3.55M | Buy |
14,692
+1,597
| +12% | +$356K | 0.03% | 489 |
|
|
2020
Q4 | $2.73M | Sell |
13,095
-12,650
| -49% | -$2.48M | 0.02% | 615 |
|
|
2020
Q3 | $4.36M | Buy |
25,745
+10,393
| +68% | +$1.83M | 0.05% | 324 |
|
|
2020
Q2 | $2.88K | Sell |
15,352
-126
| -0.8% | -$23.9K | 0.03% | 430 |
|
|
2020
Q1 | $2.74M | Sell |
15,478
-26,638
| -63% | -$5.17M | 0.03% | 531 |
|
|
2019
Q4 | $8.61M | Sell |
42,116
-53,463
| -56% | -$9.8M | 0.07% | 279 |
|
|
2019
Q3 | $14.5M | Buy |
95,579
+70,719
| +284% | +$11.5M | 0.11% | 127 |
|
|
2019
Q2 | $3.92M | Sell |
24,860
-32,384
| -57% | -$5.07M | 0.03% | 586 |
|
|
2019
Q1 | $9.21M | Buy |
57,244
+19,262
| +51% | +$3.52M | 0.08% | 225 |
|
|
2018
Q4 | $7.21M | Buy |
37,982
+17,788
| +88% | +$3.71M | 0.06% | 280 |
|
|
2018
Q3 | $4.21M | Sell |
20,194
-111,236
| -85% | -$20.6M | 0.03% | 610 |
|
|
2018
Q2 | $22.3M | Sell |
131,430
-5,037
| -4% | -$872K | 0.13% | 105 |
|
|
2018
Q1 | $22.9M | Buy |
136,467
+112,056
| +459% | +$21.8M | 0.12% | 103 |
|
|
2017
Q4 | $4.96M | Buy |
+24,411
| New | +$4.86M | 0.02% | 571 |
|
|
2017
Q3 | – | Sell |
-28,931
| Closed | -$4.84M | – | 2361 |
|
|
2017
Q2 | $4.84M | Buy |
28,931
+23,609
| +444% | +$3.79M | 0.03% | 545 |
|
|
2017
Q1 | $780K | Sell |
5,322
-98,567
| -95% | -$14.5M | 0.01% | 1387 |
|
|
2016
Q4 | $13.9M | Buy |
103,889
+46,011
| +79% | +$6.02M | 0.08% | 251 |
|
|
2016
Q3 | $7.54M | Buy |
57,878
+25,201
| +77% | +$3.29M | 0.04% | 397 |
|
|
2016
Q2 | $4.18M | Buy |
32,677
+19,175
| +142% | +$2.53M | 0.02% | 557 |
|
|
2016
Q1 | $1.85M | Sell |
13,502
-4,678
| -26% | -$642K | 0.01% | 876 |
|
|
2015
Q4 | $2.66M | Sell |
18,180
-5,135
| -22% | -$706K | 0.02% | 744 |
|
|
2015
Q3 | $3.15M | Buy |
23,315
+21,030
| +920% | +$3.05M | 0.02% | 693 |
|
|
2015
Q2 | $370K | Sell |
2,285
-765
| -25% | -$106K | ﹤0.01% | 1695 |
|
|
2015
Q1 | $395K | Sell |
3,050
-18,637
| -86% | -$2.17M | ﹤0.01% | 1476 |
|
|
2014
Q4 | $2.23M | Buy |
21,687
+18,402
| +560% | +$1.81M | 0.01% | 674 |
|
|
2014
Q3 | $298K | Sell |
3,285
-1,645
| -33% | -$154K | ﹤0.01% | 1612 |
|
|
2014
Q2 | $454K | Sell |
4,930
-22,596
| -82% | -$1.94M | ﹤0.01% | 1284 |
|
|
2014
Q1 | $2.31M | Buy |
27,526
+16,771
| +156% | +$1.38M | 0.02% | 564 |
|
|
2013
Q4 | $941K | Sell |
10,755
-42,885
| -80% | -$3.51M | 0.01% | 858 |
|
|
2013
Q3 | $4.12M | Buy |
53,640
+51,486
| +2,390% | +$4.02M | 0.04% | 371 |
|
|
2013
Q2 | $156K | Buy |
+2,154
| New | +$145K | ﹤0.01% | 1585 |
|
Other funds holding CI
Jefferies Group's CI Position: Q3 2022 in Review
Jefferies Group opened a new position in Cigna (CI) in Q3 2022: 9,400 shares worth $2.61M. The stake represents 0.02% of the portfolio and ranks #517 among its holdings. This is a return to the name: Jefferies Group previously reported a position in CI as recently as Q1 2022.
Jefferies Group first reported a position in CI in Q2 2013 and has held it in 35 quarters since. The position peaked at $22.9M in Q1 2018. 1,482 funds tracked by Wall St. Rank hold CI as of Q3 2022.
- Jefferies Group held 9,400 shares of Cigna worth $2.61M as of Q3 2022.
- Cigna was a new Jefferies Group position in Q3 2022.
- Cigna made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #517 holding.
- Jefferies Group first reported a position in Cigna in Q2 2013 and has held it in 35 quarters since.
- Jefferies Group's Cigna position peaked at $22.9M in Q1 2018.
- 1,482 funds tracked by Wall St. Rank held Cigna as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.